KMT2A and leukemia: The mechanisms underlying the KMT2A-r and KMT2A CNV pathogenesis differ in that some KMT2A-r are driver abnormalities that require very few cooperate mutations to induce tumorigenesis22, while KMT2A CNV is easily accompanied by CK, meaning it must act in coordination with other genetic abnormalities to cause leukemia.